Swiss Life Asset Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.49M | Buy |
|
|||||
|
2025
Q2 | $1.69M | Sell |
|
|||||
|
2025
Q1 | $1.66M | Buy |
|
|||||
|
2024
Q4 | $1.42M | Buy |
|
|||||
|
2024
Q3 | $420K | Sell |
|
|||||
|
2024
Q2 | $545K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $785K | Sell |
|
|||||
|
2023
Q3 | $2.9M | Buy |
|
|||||
|
2023
Q2 | $427K | Buy |
|
|||||
|
2023
Q1 | $267K | Buy |
|
|||||
|
2022
Q4 | $301K | Buy |
|